Elevance Health Files Routine 8-K on Jan 25, No Major News
Ticker: ELV · Form: 8-K · Filed: Jan 25, 2024 · CIK: 1156039
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance, routine-filing
TL;DR
**Elevance Health's 8-K is a standard administrative update, nothing to see here.**
AI Summary
Elevance Health, Inc. filed an 8-K on January 25, 2024, reporting an "Other Event" that occurred on January 23, 2024. This filing is a routine disclosure, primarily updating administrative details such as the company's current name, previous names (Anthem, Inc. and WELLPOINT, INC), and contact information. For investors, this filing indicates no significant operational or financial changes, suggesting business as usual for the healthcare giant.
Why It Matters
This filing is largely administrative, confirming basic company information and indicating no immediate material changes that would impact the stock's value or an investor's decision.
Risk Assessment
Risk Level: low — The filing contains no new material information that would introduce or alter investment risk.
Analyst Insight
A smart investor would recognize this as a routine administrative filing with no new material information, thus requiring no immediate action regarding their investment in ELV.
Key Numbers
- 001-16751 — Commission File Number (Identifies Elevance Health, Inc. with the SEC.)
- 35-2145715 — IRS Employer Identification No. (Identifies Elevance Health, Inc. for tax purposes.)
Key Players & Entities
- Elevance Health, Inc. (company) — the registrant filing the 8-K
- Anthem, Inc. (company) — a former name of Elevance Health, Inc.
- WELLPOINT, INC (company) — a former name of Elevance Health, Inc.
- January 25, 2024 (date) — the filing date of the 8-K
- January 23, 2024 (date) — the date of the earliest event reported in the 8-K
- 001-16751 (number) — the Commission File Number for Elevance Health, Inc.
- 35-2145715 (number) — the IRS Employer Identification No. for Elevance Health, Inc.
- Indiana (company) — State of incorporation for Elevance Health, Inc.
- 220 Virginia Ave Indianapolis , IN 46204 (company) — Address of principal executive offices for Elevance Health, Inc.
- 833-401-1577 (number) — Registrant’s telephone number for Elevance Health, Inc.
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is Elevance Health, Inc.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 23, 2024.
What is the trading symbol for Elevance Health, Inc. Common Stock?
The trading symbol for Elevance Health, Inc. Common Stock is ELV.
On which exchange is Elevance Health, Inc. Common Stock registered?
Elevance Health, Inc. Common Stock is registered on the New York Stock Exchange.
What were the former names of Elevance Health, Inc. mentioned in the filing?
The former names of Elevance Health, Inc. mentioned in the filing were Anthem, Inc. (date of name change: 20141202) and WELLPOINT, INC (date of name change: 20100105 and 20041130).
Filing Stats: 399 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-01-25 17:20:52
Key Financial Figures
- $0.01 — ich registered Common Stock, Par Value $0.01 ELV New York Stock Exchange Indica
- $1.63 — vidend to the Company's shareholders of $1.63 per share. This quarterly dividend is p
Filing Documents
- d743645d8k.htm (8-K) — 20KB
- 0001193125-24-015557.txt ( ) — 134KB
- elv-20240123.xsd (EX-101.SCH) — 3KB
- elv-20240123_lab.xml (EX-101.LAB) — 17KB
- elv-20240123_pre.xml (EX-101.PRE) — 11KB
- d743645d8k_htm.xml (XML) — 3KB
01 – Other Events
Item 8.01 – Other Events On January 23, 2024, the Audit Committee of the Board of Directors of Elevance Health, Inc. (the "Company") declared a quarterly cash dividend to the Company's shareholders of $1.63 per share. This quarterly dividend is payable on March 22, 2024 to shareholders of record as of March 8, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 25 th day of January, 2024. ELEVANCE HEALTH, INC. By: /s/ Kathleen S. Kiefer Name: Kathleen S. Kiefer Title: Chief Governance Officer and Corporate Secretary